Open Beta
TREN
MetriLume
TREN

US marketsPHAT

SEC-sourced researchBeta

PHAT

Phathom Pharmaceuticals, Inc.

Company comparison ↗

Data passport

CIK
0001783183
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 29, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 55,252,000.0000 USD; December 2025: 175,110,000.0000 USD175.1M USD0 USD0December 2024December 2025
PHAT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202455,252,000.0000Feb 26, 2026
December 2025175,110,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025175,110,000.0000-221,247,000.0000-166,775,000.0000259,149,000.0000697,318,000.0000Feb 26, 2026
December 202455,252,000.0000-334,326,000.0000-266,770,000.0000378,318,000.0000631,898,000.0000Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$175.11MDecember 2025Feb 26, 202610-K
Previous period revenueRevenues$55.25MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$221.25MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$166.78MDecember 2025Feb 26, 202610-K
Total assetsAssets$259.15MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$697.32MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗